Search results
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 5 hours agoIn December 2023, the two companies enrolled the first subjects in the Phase III INTerpath-002 study...
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 5 days agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
InvestorPlace· 3 hours agoUndervalued biotech stocks can offer some of the most explosive opportunities. Many times, biotech...
FDA advisers consider MDMA therapy to treat PTSD - WSVN 7News | Miami News, Weather, Sports | Fort...
7 News Miami· 38 minutes agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 hour agoPALO ALTO, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced ...
Claims of Misconduct Mar MDMA Research for PTSD
High Times· 3 hours agoMedical research into using the psychedelic MDMA to treat post-traumatic stress disorder is being called into question following allegations that a clinical trial ...
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
Clinical Trials Arena via Yahoo Finance· 1 day agoLast year, Genmab and Seagen reported additional positive results from the Phase III clinical trial ...
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
Clinical Trials Arena via Yahoo Finance· 5 days agoLexicon Pharmaceuticals has chosen clinical trial solutions provider Medidata to help advance the ...
Test of Male Birth Control Treatment Produces Promising Results
Futurism via Yahoo News· 21 hours agoIn clinical trials, a new male birth control gel seems to adequately reduce sperm count without...
AusperBio to Present AHB-137 Clinical Data Updates at EASL™ Congress 2024
KPVI· 7 days ago– The company to present important new data from two Phase I trials of its leading molecule, AHB-137, aimed at achieving a functional cure for chronic hepatitis ...